MetLife Investment Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
31,444
+5,114
| +19% | +$295K | 0.01% | 1038 |
|
|
2025
Q1 | $1.53M | Sell |
26,330
-350
| -1% | -$20.4K | 0.01% | 1165 |
|
|
2024
Q4 | $2.15M | Buy |
26,680
+2,144
| +9% | +$173K | 0.01% | 998 |
|
|
2024
Q3 | $1.97M | Hold |
24,536
| – | – | 0.01% | 1025 |
|
|
2024
Q2 | $1.5M | Buy |
24,536
+4,060
| +20% | +$248K | 0.01% | 1124 |
|
|
2024
Q1 | $1.01M | Sell |
20,476
-860
| -4% | -$42.5K | 0.01% | 1294 |
|
|
2023
Q4 | $894K | Buy |
21,336
+2,142
| +11% | +$89.8K | 0.01% | 1358 |
|
|
2023
Q3 | $630K | Hold |
19,194
| – | – | ﹤0.01% | 1483 |
|
|
2023
Q2 | $679K | Buy |
19,194
+5,396
| +39% | +$191K | ﹤0.01% | 1494 |
|
|
2023
Q1 | $392K | Hold |
13,798
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q4 | $573K | Hold |
13,798
| – | – | ﹤0.01% | 1557 |
|
|
2022
Q3 | $572K | Hold |
13,798
| – | – | ﹤0.01% | 1544 |
|
|
2022
Q2 | $451K | Buy |
13,798
+8,790
| +176% | +$287K | ﹤0.01% | 1732 |
|
|
2022
Q1 | $175K | Buy |
+5,008
| New | +$175K | ﹤0.01% | 2435 |
|